Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Maryland, Baltimore, Dana-Farber Cancer Institute, Johns Hopkins University, Mayo Clinic, University of Pennsylvania, University of Pittsburgh, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, University of Miami, The University of Texas MD Anderson Cancer Center, Emory University, Winship Cancer Institute, University of Iowa, Yale Cancer Center, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4293074097